BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35332409)

  • 1. How to improve O-RADS MRI score for rating adnexal masses with cystic component?
    Assouline V; Dabi Y; Jalaguier-Coudray A; Stojanovic S; Millet I; Reinhold C; Bazot M; Thomassin-Naggara I;
    Eur Radiol; 2022 Sep; 32(9):5943-5953. PubMed ID: 35332409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.
    Hottat NA; Badr DA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    J Magn Reson Imaging; 2022 Jul; 56(1):158-170. PubMed ID: 34797013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-RADS MRI score: analysis of misclassified cases in a prospective multicentric European cohort.
    Thomassin-Naggara I; Belghitti M; Milon A; Abdel Wahab C; Sadowski E; Rockall AG;
    Eur Radiol; 2021 Dec; 31(12):9588-9599. PubMed ID: 34041567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving risk stratification of indeterminate adnexal masses on MRI: What imaging features help predict malignancy in O-RADS MRI 4 lesions?
    Wong BZY; Causa Andrieu PI; Sonoda Y; Chi DS; Aviki EM; Vargas HA; Woo S
    Eur J Radiol; 2023 Nov; 168():111122. PubMed ID: 37806193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Adding Mean Apparent Diffusion Coefficient (ADCmean) Measurements to O-RADS MRI Scoring For Adnexal Lesions Characterization: A Combined O-RADS MRI/ADCmean Approach.
    Elshetry ASF; Hamed EM; Frere RAF; Zaid NA
    Acad Radiol; 2023 Feb; 30(2):300-311. PubMed ID: 36085271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance scoring system for assessment of adnexal masses: added value of diffusion-weighted imaging including apparent diffusion coefficient map.
    Hottat NA; Van Pachterbeke C; Vanden Houte K; Denolin V; Jani JC; Cannie MM
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):478-487. PubMed ID: 32438461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.
    Wu M; Tang Q; Cai S; Zhu L; Lin C; Guan Y; Rao S; Zhou J
    Eur J Radiol; 2023 Feb; 159():110670. PubMed ID: 36584564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O-RADS MRI Classification of Indeterminate Adnexal Lesions: Time-Intensity Curve Analysis Is Better Than Visual Assessment.
    Wengert GJ; Dabi Y; Kermarrec E; Jalaguier-Coudray A; Poncelet E; Porcher R; Thomassin-Naggara I; Rockall AG;
    Radiology; 2022 Jun; 303(3):566-575. PubMed ID: 35230183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.
    Rizzo S; Cozzi A; Dolciami M; Del Grande F; Scarano AL; Papadia A; Gui B; Gandolfo N; Catalano C; Manganaro L
    Radiology; 2023 Apr; 307(1):e220795. PubMed ID: 36413127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-RADS MRI SCORE: An Essential First-Step Tool for the Characterization of Adnexal Masses.
    Thomassin-Naggara I; Dabi Y; Florin M; Saltel-Fulero A; Manganaro L; Bazot M; Razakamanantsoa L
    J Magn Reson Imaging; 2024 Mar; 59(3):720-736. PubMed ID: 37550825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of American College of Radiology Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US): Analysis on 1054 adnexal masses.
    Cao L; Wei M; Liu Y; Fu J; Zhang H; Huang J; Pei X; Zhou J
    Gynecol Oncol; 2021 Jul; 162(1):107-112. PubMed ID: 33966893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery.
    Dabi Y; Rockall A; Razakamanantsoa L; Guerra A; Fournier LS; Fotopoulou C; Touboul C; Thomassin-Naggara I;
    Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():135-142. PubMed ID: 38237312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bridging Communication Gaps Between Radiologists, Referring Physicians, and Patients Through Standardized Structured Cancer Imaging Reporting: The Experience with Female Pelvic MRI Assessment Using O-RADS and a Simulated Cohort Patient Group.
    Woo S; Andrieu PC; Abu-Rustum NR; Broach V; Zivanovic O; Sonoda Y; Chi DS; Aviki E; Ellis A; Carayon P; Hricak H; Vargas HA
    Acad Radiol; 2024 Apr; 31(4):1388-1397. PubMed ID: 37661555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.
    Thomassin-Naggara I; Poncelet E; Jalaguier-Coudray A; Guerra A; Fournier LS; Stojanovic S; Millet I; Bharwani N; Juhan V; Cunha TM; Masselli G; Balleyguier C; Malhaire C; Perrot NF; Sadowski EA; Bazot M; Taourel P; Porcher R; Darai E; Reinhold C; Rockall AG
    JAMA Netw Open; 2020 Jan; 3(1):e1919896. PubMed ID: 31977064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score.
    Manganaro L; Ciulla S; Celli V; Ercolani G; Ninkova R; Miceli V; Cozzi A; Rizzo SM; Thomassin-Naggara I; Catalano C
    Radiol Med; 2023 May; 128(5):565-577. PubMed ID: 37097348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions.
    Zhang Q; Dai X; Li W
    AJR Am J Roentgenol; 2023 Jul; 221(1):21-33. PubMed ID: 36722758
    [No Abstract]   [Full Text] [Related]  

  • 17. ADC-derived spatial features can accurately classify adnexal lesions.
    Fathi Kazerooni A; Nabil M; Haghighat Khah H; Alviri M; Heidari-Sooreshjaani M; Gity M; Malek M; Saligheh Rad H
    J Magn Reson Imaging; 2018 Apr; 47(4):1061-1071. PubMed ID: 28901638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of IOTA Simple Rules, Simple Rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in North American women.
    Hiett AK; Sonek JD; Guy M; Reid TJ
    Ultrasound Obstet Gynecol; 2022 May; 59(5):668-676. PubMed ID: 34533862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features of cystadenofibroma on magnetic resonance imaging: an update using the O-RADS lexicon and considering diffusion-weighted and perfusion imaging.
    Avesani G; Elia L; Anghelone AG; Perazzolo A; Panico C; Di Paola V; Gui B; Rodolfino E; Moro F; Testa AC; Manfredi R
    Eur J Radiol; 2022 Sep; 154():110429. PubMed ID: 35797789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology.
    Gong LP; Li XY; Wu YN; Dong S; Zhang S; Feng YN; Lv YE; Guo XJ; Peng YQ; Du XS; Tian JW; Sun CX; Sun LT
    J Ovarian Res; 2023 Mar; 16(1):57. PubMed ID: 36945000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.